Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.80 |
| ▸ | GAA | P10253 | 1/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 1/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.73 |
| ▸ | SNCA | P37840 | 2/20 | 0.70 |
| ▸ | FDPS | P14324 | 3/20 | 0.68 |
| ▸ | ACHE | P22303 | 4/20 | 0.67 |
| ▸ | APP | P05067 | 2/20 | 0.66 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA3 | P07451 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.61 |
| ▸ | CA4 | P22748 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cinametic Acid SCHEMBL11681943 | 1.00 | KDM4E (0.80) | KDM4EGAAKMT2AALDH1A1HPGD | |
| Cinametic Acid SCHEMBL29926813 | 1.00 | KDM4E (0.80) | KDM4EGAAKMT2AALDH1A1HPGD | |
| SCHEMBL14229893 | 0.93 | KDM4E (0.86) | KDM4EGAAKMT2AALDH1A1HPGD | |
| SCHEMBL6879248 | 0.92 | KDM4E (0.76) | KDM4EGAAKMT2AALDH1A1HPGD | |
| SCHEMBL13168863 | 0.92 | KDM4E (0.84) | KDM4EGAAKMT2AALDH1A1HPGD | |
| SCHEMBL17223787 | 0.91 | KDM4E (0.86) | KDM4EGAAKMT2AALDH1A1HPGD | |
| SCHEMBL17223789 | 0.91 | KDM4E (0.86) | KDM4EGAAKMT2AALDH1A1HPGD | |
| SCHEMBL7552212 | 0.91 | KDM4E (0.74) | KDM4EGAAKMT2AALDH1A1HPGD | |
| SCHEMBL8410643 | 0.91 | KDM4E (0.74) | KDM4EGAAKMT2AALDH1A1HPGD | |
| SCHEMBL13168868 | 0.90 | KDM4E (0.82) | KDM4EGAAKMT2AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| WO-2011124227-A1 | BIOCIDAL ACID-ADJUSTED POLYMER WITH POLYPROPYLENE | VESTERGAARD FRANDSEN SA (CH) | 2011-10-13 | — | — | WO | claimed |
| WO-2011124228-A1 | A BIOCIDAL POLYOLEFIN YARN WITH 3-12 FILAMENTS | VESTERGAARD FRANDSEN SA (CH) | 2011-10-13 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |
| EP-3752201-A1 | SUSPENSION OF NANOSCALE, ORGANIC PARTICLES AND PROCESS FOR PRODUCTION THEREOF | Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) | 2020-12-23 | — | — | EP | disclosed |
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2020-06-23 | — | — | US | disclosed |
| US-20200165192-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2020-05-28 | — | — | US | disclosed |
| US-10550072-B2 | Amino acid derivatives and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2020-02-04 | — | — | US | disclosed |
| US-10463611-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| US-20060172983-A1 | Functionalized drugs and polymers derived therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2006-08-03 | — | — | US | disclosed |
| CN-1523980-A | Pharmaceutical formulations containing an active dispersed in a matrix | ��̹��ҽҩ��˾ | 2004-08-25 | — | — | CN | disclosed |
| US-20040058896-A1 | Pharmaceutical preparation comprising an active dispersed on a matrix | ASTRAZENECA AB (SE) | 2004-03-25 | — | — | US | disclosed |
| EP-1341527-A1 | PHARMACEUTICAL PREPARATION COMPRISING AN ACTIVE DISPERSED ON A MATRIX | ALTANA Pharma AG (DE) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002045693-A1 | PHARMACEUTICAL PREPARATION COMPRISING AN ACTIVE DISPERSED ON A MATRIX | ALTANA PHARMA AG (DE) | 2002-06-13 | — | — | WO | disclosed |
| CN-1201199-A | Eight-queen stereo digital-image programming method and use for software library programming computor thereof | WU ZONGSHENG (CN) | 1998-12-09 | — | — | CN | disclosed |
| US-4053415-A | UNSATURATED POLYESTER ETHER HAVING A PHOTOCROSSLINKABLE MOIETY | FUJI PHOTO FILM CO., LTD. (JA) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550072-B2 | Amino acid derivatives and absorbable polymers therefrom | SRRM2, SLC7A1, BCAT2 | KDM4E 2679/4885GAA 2510/4885KMT2A 1431/4885 |
| US-10689330-B2 | Amino acid derivatives and absorbable polymers therefrom | SRRM2, SLC7A1, BCAT2 | KDM4E 2679/4885GAA 2510/4885KMT2A 1431/4885 |
| US-20060172983-A1 | Functionalized drugs and polymers derived therefrom | OGFR, LOX, OPRM1 | KDM4E 1584/4885GAA 804/4885KMT2A 3676/4885 |
| US-20200165192-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | KDM4E 2679/4885GAA 2510/4885KMT2A 1431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.